Method for the humanization of antibodies and humanized antibodies thereby obtained

Details for Australian Patent Application No. 2004303633 (hide)

Owner Lay Line Genomics S.p.A. Scuola Internazionale Superiore Di Studi Avanzati-SISSA

Inventors Lamba, Doriano; Cattaneo, Antonino; Covaceuszach, Sonia

Agent FB Rice

Pub. Number AU-B-2004303633

PCT Pub. Number WO2005/061540

Priority RM2003000601 24.12.03 IT

Filing date 23 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 8 December 2011

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061540 Priority application(s): WO2005/061540

8 December 2011 Application Accepted

  Published as AU-B-2004303633

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303635-Tin-doped indium oxide microparticle dispersion, process for producing the same, interlayer for laminated glass having heat-ray blocking property produced with the dispersion, and laminated glass

2004303629-Methods for detection of Mycobacterium tuberculosis